One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit

被引:0
|
作者
Christopher McCabe
Mike Paulden
Isaac Awotwe
Andrew Sutton
Peter Hall
机构
[1] Institute of Health Economics,School of Public Health
[2] University of Alberta,Department of Economics
[3] University of Alberta,Department of Oncology
[4] University of Edinburgh,Department of Emergency Medicine
[5] University of Alberta,undefined
来源
PharmacoEconomics | 2020年 / 38卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although probabilistic analysis has become the accepted standard for decision analytic cost-effectiveness models, deterministic one-way sensitivity analysis continues to be used to meet the need of decision makers to understand the impact that changing the value taken by one specific parameter has on the results of the analysis. The value of a probabilistic form of one-way sensitivity analysis has been recognised, but the proposed methods are computationally intensive. Deterministic one-way sensitivity analysis provides decision makers with biased and incomplete information whereas, in contrast, probabilistic one-way sensitivity analysis (POSA) can overcome these limitations, an observation supported in this study by results obtained when these methods were applied to a previously published cost-effectiveness analysis to produce a conditional incremental expected net benefit curve. The application of POSA will provide decision makers with unbiased information on how the expected net benefit is affected by a parameter taking on a specific value and the probability that the specific value will be observed.
引用
收藏
页码:135 / 141
页数:6
相关论文
共 50 条
  • [1] One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
    McCabe, Christopher
    Paulden, Mike
    Awotwe, Isaac
    Sutton, Andrew
    Hall, Peter
    [J]. PHARMACOECONOMICS, 2020, 38 (02) : 135 - 141
  • [2] Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier
    Christopher McCabe
    Giovanni Tramonti
    Andrew Sutton
    Peter Hall
    Mike Paulden
    [J]. PharmacoEconomics, 2021, 39 : 19 - 24
  • [3] Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier
    McCabe, Christopher
    Tramonti, Giovanni
    Sutton, Andrew
    Hall, Peter
    Paulden, Mike
    [J]. PHARMACOECONOMICS, 2021, 39 (01) : 19 - 24
  • [4] COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATION
    Campbell, J.
    McQueen, R. B.
    Libby, A.
    Briggs, A.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A5 - A5
  • [5] COST-EFFECTIVENESS UNCERTAINTY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATION
    Campbell, J.
    McQueen, R. B.
    Libby, A. M.
    Spackman, E.
    Carlson, J.
    Briggs, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A468 - A468
  • [6] Cost-Effectiveness Uncertainty Analysis Methods: A Comparison of One-Way Sensitivity, Analysis of Covariance, and Expected Value of Partial Perfect Information
    Campbell, Jonathan D.
    McQueen, R. Brett
    Libby, Anne M.
    Spackman, D. Eldon
    Carlson, Joshua J.
    Briggs, Andrew
    [J]. MEDICAL DECISION MAKING, 2015, 35 (05) : 596 - 607
  • [7] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
    O'Mahony, James F.
    [J]. PHARMACOECONOMICS, 2020, 38 (08) : 777 - 779
  • [8] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
    James F. O’Mahony
    [J]. PharmacoEconomics, 2020, 38 : 777 - 779
  • [9] A COMPUTATIONALLY EFFICIENT ALTERNATIVE METHOD FOR PROBABILISTIC ONE-WAY SENSITIVITY ANALYSIS
    Gal, P.
    Benedict, A.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S200 - S201
  • [10] Incremental Net Monetary Benefit of Bariatric Surgery: Systematic Review and Meta-Analysis of Cost-Effectiveness Evidences
    Prapaporn Noparatayaporn
    Montarat Thavorncharoensap
    Usa Chaikledkaew
    Bhavani Shankara Bagepally
    Ammarin Thakkinstian
    [J]. Obesity Surgery, 2021, 31 : 3279 - 3290